| payload |
{"created_at":"2026-04-20T14:04:30.285 {"created_at":"2026-04-20T14:04:30.285335+00:00","dedupe_key":"signal_enriched:news_delta:6c88c4674c26ad91","evidence_event_ids":["evt_d4ab5b6727df"],"signal_type":"news_headline_delta","source":"news_rss","value":{"aggregator_url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNeU8tZ1NfcGcxTVdQV3BMUUNGc3ZObGU2UWY0clFISDZjeEtfWDg2THl3T1VFc0dLa3ZkQi1zODRMTkp0dnJoc1hqV2dxeDZqV2lsLXZvQ0x1T1lSY3c4c2pfc1JUbG9GRHJ0SWJkVFhJckpqN0NUNHk2M1d6R2RqNlFCNkNKcGZB?oc=5","as_of":"2026-04-20T14:04:30.285335+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNeU8tZ1NfcGcxTVdQV3BMUUNGc3ZObGU2UWY0clFISDZjeEtfWDg2THl3T1VFc0dLa3ZkQi1zODRMTkp0dnJoc1hqV2dxeDZqV2lsLXZvQ0x1T1lSY3c4c2pfc1JUbG9GRHJ0SWJkVFhJckpqN0NUNHk2M1d6R2RqNlFCNkNKcGZB?oc=5","article_chars":0,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_5c458c351ae5b3ac","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-20T14:04:50.437980+00:00","extraction_method":"none","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNeU8tZ1NfcGcxTVdQV3BMUUNGc3ZObGU2UWY0clFISDZjeEtfWDg2THl3T1VFc0dLa3ZkQi1zODRMTkp0dnJoc1hqV2dxeDZqV2lsLXZvQ0x1T1lSY3c4c2pfc1JUbG9GRHJ0SWJkVFhJckpqN0NUNHk2M1d6R2RqNlFCNkNKcGZB?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"wsj.com","publisher_resolution":"payload_source_domain","requested_url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNeU8tZ1NfcGcxTVdQV3BMUUNGc3ZObGU2UWY0clFISDZjeEtfWDg2THl3T1VFc0dLa3ZkQi1zODRMTkp0dnJoc1hqV2dxeDZqV2lsLXZvQ0x1T1lSY3c4c2pfc1JUbG9GRHJ0SWJkVFhJckpqN0NUNHk2M1d6R2RqNlFCNkNKcGZB?oc=5","source_event_id":"evt_d4ab5b6727df","source_quality":"empty","status_code":200,"version":"signal_enrichment_v2"},"fp":"183800bdd5944f80","published_at":"2026-04-20T13:35:00+00:00","publisher_domain":"wsj.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.42,"dates_mentioned":[],"entities":[],"event_type":"other","information_gaps":["article_text_unavailable"],"key_facts":["Headline: Exclusive | Eli Lilly Nears Deal for Cancer Biotech - WSJ","Source summary: Exclusive | Eli Lilly Nears Deal for Cancer Biotech WSJ Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion CNBC Eli Lilly Closes in on a $2 Billion M&A Deal. What It Means for the Stock. Barron's Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company investor.lilly.com Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 b"],"numeric_claims":[],"primary_claim":"Exclusive | Eli Lilly Nears Deal for Cancer Biotech - WSJ","relevance_score":0.46,"sentiment":"neutral","source_quality":"unknown","summary":"Exclusive | Eli Lilly Nears Deal for Cancer Biotech WSJ Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion CNBC Eli Lilly Closes in on a $2 Billion M&A Deal. What It Means for the Stock. Barron's Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company investor.lilly.com Lilly in advanced talks to acquire Kelonia Therap","topics":["news headline"]},"source":"WSJ","source_domain":"wsj.com","source_url":"https://www.wsj.com","summary":"Exclusive | Eli Lilly Nears Deal for Cancer Biotech WSJ Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion CNBC Eli Lilly Closes in on a $2 Billion M&A Deal. What It Means for the Stock. Barron's Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company investor.lilly.com Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says Yahoo","title":"Exclusive | Eli Lilly Nears Deal for Cancer Biotech - WSJ","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.z46LtA-qfIg.L.X.O/am=GAIFAACAA2YBAwpA/d=1/ed=1/rs=ALs0n2PeUbKSDKfQ9Op-3wUE_8hlNgDpuA/m=syndicationarticleview,_b,_tp"}}... |